Avsnitt Episode 5: SGLT2 inhibitors reduce CV mortality Primary Care POEM of the Week with Drs. Mark Ebell and Mike Wilkes Spela Dela
This week, Drs Wilkes and Ebell discuss a new meta-analysis of the CV benefit of SGLT-2 inhibitors, which is less dramatic than you might think. Rss Apple Podcaster →
